DCGO — DocGo Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Annual income statement for DocGo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	319	441	624	617	322
Cost of Revenue
Gross Profit	110	155	195	214	98.8
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	303	420	609	596	505
Operating Profit	15.5	20.5	15.1	20.4	-183
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	19.8	22.8	16.3	27.7	-187
Provision for Income Taxes
Net Income After Taxes	19.2	30.7	10	13.4	-196
Minority Interest
Net Income Before Extraordinary Items
Net Income	23.7	34.6	6.86	20	-182
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	23.7	34.6	6.86	20	-182
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.249	0.354	0.071	0.219	-1.22